Cost-effectiveness of hormone therapy in the United States.
about
Menopausal hormone therapy: a systematic review of cost-effectiveness evaluations.Evidence-based guidelines for the pharmacological treatment of postmenopausal osteoporosis: a consensus document by the Belgian Bone ClubEconomic return from the Women's Health Initiative estrogen plus progestin clinical trial: a modeling study.Optimal management of perimenopausal depressionPrevention of diseases after menopause.A systematic review of cost-effectiveness analyses of drugs for postmenopausal osteoporosis.Economic evaluation of using a genetic test to direct breast cancer chemoprevention in white women with a previous breast biopsy.
P2860
Q33644735-B319EB05-1572-41CA-AAAE-A01BD5D33D7AQ34099162-E7471F74-E991-4318-B281-FB766E18BA33Q34147730-19EADA07-5488-4F49-AA45-DB0C4E872E05Q34272115-54EC5640-3859-4C0F-AF9B-040BD89ED332Q38223587-2BCD38A1-4EE1-42BB-9E97-7BB2DC7C982CQ38265934-5C645203-423E-4969-B3E7-6745D6B77781Q50460101-2B9CE376-8203-4BEF-9C3D-FAD975CD32F6
P2860
Cost-effectiveness of hormone therapy in the United States.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
Cost-effectiveness of hormone therapy in the United States.
@en
Cost-effectiveness of hormone therapy in the United States.
@nl
type
label
Cost-effectiveness of hormone therapy in the United States.
@en
Cost-effectiveness of hormone therapy in the United States.
@nl
prefLabel
Cost-effectiveness of hormone therapy in the United States.
@en
Cost-effectiveness of hormone therapy in the United States.
@nl
P2093
P356
P1476
Cost-effectiveness of hormone therapy in the United States.
@en
P2093
Fredrik Borgström
Ingrid Lekander
John A Kanis
Niklas Zethraeus
Oskar Ström
P304
P356
10.1089/JWH.2008.1246
P577
2009-10-01T00:00:00Z